BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 15476936)

  • 1. Physiological roles of urocortins, human homologues of fish urotensin I, and their receptors.
    Suda T; Kageyama K; Sakihara S; Nigawara T
    Peptides; 2004 Oct; 25(10):1689-701. PubMed ID: 15476936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urocortins as cardiovascular peptides.
    Takahashi K; Totsune K; Murakami O; Shibahara S
    Peptides; 2004 Oct; 25(10):1723-31. PubMed ID: 15476939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
    Vaughan J; Donaldson C; Bittencourt J; Perrin MH; Lewis K; Sutton S; Chan R; Turnbull AV; Lovejoy D; Rivier C
    Nature; 1995 Nov; 378(6554):287-92. PubMed ID: 7477349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urocortins and the regulation of gastrointestinal motor function and visceral pain.
    Martinez V; Wang L; Million M; Rivier J; Taché Y
    Peptides; 2004 Oct; 25(10):1733-44. PubMed ID: 15476940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution and physiology of the corticotropin-releasing factor (CRF) family of neuropeptides in vertebrates.
    Lovejoy DA; Balment RJ
    Gen Comp Endocrinol; 1999 Jul; 115(1):1-22. PubMed ID: 10375459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ancient evolution of stress-regulating peptides in vertebrates.
    Chang CL; Hsu SY
    Peptides; 2004 Oct; 25(10):1681-8. PubMed ID: 15476935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
    Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
    Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides.
    Boorse GC; Denver RJ
    Gen Comp Endocrinol; 2006 Mar; 146(1):9-18. PubMed ID: 16413023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
    Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders.
    Behan DP; Grigoriadis DE; Lovenberg T; Chalmers D; Heinrichs S; Liaw C; De Souza EB
    Mol Psychiatry; 1996 Sep; 1(4):265-77. PubMed ID: 9118350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart.
    Yang LZ; Tovote P; Rayner M; Kockskämper J; Pieske B; Spiess J
    Eur J Pharmacol; 2010 Apr; 632(1-3):1-6. PubMed ID: 20132811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
    Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE
    Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
    Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
    Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
    Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
    Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-amino acid motifs of urocortin II and III determine their CRF receptor subtype selectivity.
    Jahn O; Tezval H; van Werven L; Eckart K; Spiess J
    Neuropharmacology; 2004 Aug; 47(2):233-42. PubMed ID: 15223302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rainbow trout (Oncorhynchus mykiss) urotensin-I: structural differences between urotensins-I and urocortins.
    Barsyte D; Tipping DR; Smart D; Conlon JM; Baker BI; Lovejoy DA
    Gen Comp Endocrinol; 1999 Aug; 115(2):169-77. PubMed ID: 10417230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urocortin and cardiovascular protection.
    Huang Y; Yao XQ; Lau CW; Chan YC; Tsang SY; Chan FL
    Acta Pharmacol Sin; 2004 Mar; 25(3):257-65. PubMed ID: 15000874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord.
    Korosi A; Kozicz T; Richter J; Veening JG; Olivier B; Roubos EW
    J Comp Neurol; 2007 Jun; 502(6):973-89. PubMed ID: 17444496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular functions of urocortin].
    Cong BH; Ni X
    Sheng Li Ke Xue Jin Zhan; 2005 Oct; 36(4):349-52. PubMed ID: 16408778
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular cloning and functional expression of the mouse CRF2(a) receptor splice variant.
    Dautzenberg FM; Higelin J; Wille S; Brauns O
    Regul Pept; 2004 Sep; 121(1-3):89-97. PubMed ID: 15256278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.